Skip to main content
. Author manuscript; available in PMC: 2021 Apr 22.
Published in final edited form as: Neurology (ECronicon). 2021 Jan 30;13(2):19–33.

Table 5:

The mean normalized abundance of phyla in control-period fecal samples (95% CI) compared to Post-OMM (95% CI; p-value of within-subject repeated measures ANOVA) with the percent change across sessions (p-values of Bonferroni pairwise comparison).

Phylum Mean Normalized Abundance % Change (P-value) Effect Size (d)
Pre-OMM (95% CI) Post-OMM (95% CI; p-value)
Actinobacteria 61096 (42002, 88870) 39496 (28285, 55150; p = .040)* 2.2% (.001) 0.845
Bacteroidetes 354826 (273992, 459508) 305406 (262022, 355973; p = 1.000) 10.2% (< .001) 0.496
Euryarchaeota 40758 (18318, 90691) 15862 (7899, 31852; p = .160) 2.9% (< .001) 0.712
Fibrobacteres 71 (43, 117) 267.0 (127, 562; p = .080) 0.0% (< .001) 0.676
Firmicutes 480735 (415254, 556542) 599474 (537265, 668886; p = .080) 1.1% (< .001) 1.274
Lentisphaerae 1803 (427, 7625) 1639 (607, 4426; p = 1.000) 0.2% (.130) 0.047
Proteobacteria 26230 (20936, 32863) 31048 (14733, 65428; p = 1.000) 0.9% (.032) 0.208
Verrucomicrobia 111313 (68898, 179840) 28076 (13237, 59547; p = .024)* 8.5% (< .001) 0.675
Synergistetes 18047 (−9966, 46060) 4851 (−2780, 12481; p = .175) 1.3% (.175) 0.675
Deinococcus-Thermus 0 (0, 0) 5 (−7, 17; p = .363) 0.0% (.363) 0.577
Fusobacteria 4 (−6, 14) 7 (−11, 26; p = .720) 0.0% (.720) 0.237

Effect size Cohen’s d categories were: ≤ 0.2 = small, ≤ 0.5 = moderate, ≥ 0.8 = large for the change in abundance of phyla.

*

p ≤ .050.